Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Gross Profit (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Gross Profit for 6 consecutive years, with $50.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit fell 9.15% year-over-year to $50.4 million, compared with a TTM value of $169.8 million through Dec 2025, up 0.88%, and an annual FY2025 reading of $169.8 million, up 0.88% over the prior year.
  • Gross Profit was $50.4 million for Q4 2025 at Treace Medical Concepts, up from $39.7 million in the prior quarter.
  • Across five years, Gross Profit topped out at $55.5 million in Q4 2024 and bottomed at $15.4 million in Q1 2021.
  • Average Gross Profit over 5 years is $34.2 million, with a median of $35.0 million recorded in 2023.
  • The sharpest move saw Gross Profit surged 195.54% in 2021, then fell 9.15% in 2025.
  • Year by year, Gross Profit stood at $28.1 million in 2021, then skyrocketed by 45.17% to $40.7 million in 2022, then grew by 24.53% to $50.7 million in 2023, then rose by 9.33% to $55.5 million in 2024, then fell by 9.15% to $50.4 million in 2025.
  • Business Quant data shows Gross Profit for TMCI at $50.4 million in Q4 2025, $39.7 million in Q3 2025, and $37.8 million in Q2 2025.